This is the classic website, which will be retired eventually. Please visit the modernized ClinicalTrials.gov instead.
Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

An Open-Label Extension Study of BPN14770 in Subjects With Fragile X Syndrome

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT05367960
Recruitment Status : Enrolling by invitation
First Posted : May 10, 2022
Last Update Posted : January 25, 2024
Sponsor:
Information provided by (Responsible Party):
Tetra Discovery Partners

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Enrolling by invitation
Estimated Primary Completion Date : February 2024
Estimated Study Completion Date : December 2025